No person-to-person spread has been detected, but that doesn’t mean an H5N1 avian influenza pandemic isn’t possible or even ...

The US Department of HHS is awarding the pharmaceutical company Moderna $590 million to continue developing a vaccine to protect against bird flu.

While drugmakers are hard at work on the shots, they’re not yet ready to blunt the impact of a potential pandemic.

The number of bird flu cases in Central Massachusetts is relatively low, compared to a swath of the state that runs from ...

As more cases of bird flu emerge across the country, public health leaders in New York City are watching warily -- and making ...

The Centers for Disease Control and Prevention abruptly ordered its staff to cease all collaboration with the World Health ...

There is currently no vaccine for bird flu, but the U.S. Department of Health and Human Services recently announced $590 million in funding for Moderna to expedite the development of an mRNA ...

Efforts have also ramped up to accelerate bird flu vaccine development. Last week, the federal Department of Health and Human Services announced it would provide about $590 million to Moderna to ...

Moderna’s efforts to develop a range of mRNA ... hospitalised with influenza to see if they are suffering from bird flu, says CDC. Join the conversation, on Tuesday 28th January @ 10 am ET ...

The first human bird flu death in the US has Moderna's vaccine development in focus for investors this week. Recently, Zacks.com users have been paying close attention to Novavax (NVAX).

The first human bird flu death in the US has Moderna's vaccine development in focus for investors this week. Recently, Zacks.com users have been paying close attention to Novavax (NVAX). This makes it ...